Flexion Therapeutics, Inc. Selling, General and Administrative Expense
Flexion Therapeutics, Inc. reported Selling, General and Administrative Expense of $26.99 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2021-11-12
- Flexion Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2021-09-30 was $26.99M, a 1.19% decline year-over-year.
- Flexion Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2021-06-30 was $27.41M, a 10.83% increase year-over-year.
- Flexion Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2021-03-31 was $27.60M, a 5.81% decline year-over-year.
- Flexion Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2020-12-31 was $23.66M, a 26.65% decline year-over-year.
- Flexion Therapeutics, Inc. selling, general and administrative expense for fiscal 2020 was $105.00M, a 19.05% decline from fiscal 2019.
- Flexion Therapeutics, Inc. selling, general and administrative expense for fiscal 2019 was $129.71M, a 6.92% increase from fiscal 2018.
- Flexion Therapeutics, Inc. selling, general and administrative expense for fiscal 2018 was $121.31M.
- Flexion Therapeutics, Inc. selling, general and administrative expense for fiscal 2016 was $28.47M, a 112.88% increase from fiscal 2015.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2021-09-30 | $26.99M 10-Q · filed 2021-11-12 | $54.40M derived: sum of 2 quarters · filed 2021-11-12 | $81.99M 10-Q · filed 2021-11-12 | $105.65M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $27.41M 10-Q · filed 2021-08-04 | $55.01M 10-Q · filed 2021-08-04 | $78.66M derived: sum of 3 quarters · filed 2021-08-04 | $105.97M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | $27.60M 10-Q · filed 2021-05-12 | $51.25M derived: sum of 2 quarters · filed 2021-05-12 | $78.56M derived: sum of 3 quarters · filed 2021-11-12 | $103.30M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | $23.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $50.97M derived: sum of 2 quarters · filed 2021-11-12 | $75.70M derived: sum of 3 quarters · filed 2021-11-12 | $105.00M 10-K · filed 2021-03-10 |
| 2020-09-30 | $27.31M 10-Q · filed 2021-11-12 | $52.04M derived: sum of 2 quarters · filed 2021-11-12 | $81.34M 10-Q · filed 2021-11-12 | $113.59M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $24.73M 10-Q · filed 2021-08-04 | $54.03M 10-Q · filed 2021-08-04 | $86.28M derived: sum of 3 quarters · filed 2021-08-04 | $118.41M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $29.30M 10-Q · filed 2021-05-12 | $61.55M derived: sum of 2 quarters · filed 2021-05-12 | $93.68M derived: sum of 3 quarters · filed 2021-05-12 | $126.79M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $32.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $64.38M derived: sum of 2 quarters · filed 2021-03-10 | $97.49M derived: sum of 3 quarters · filed 2021-03-10 | $129.71M 10-K · filed 2021-03-10 |
| 2019-09-30 | $32.14M 10-Q · filed 2020-11-04 | $65.24M derived: sum of 2 quarters · filed 2020-11-04 | $97.46M 10-Q · filed 2020-11-04 | $128.03M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | $33.10M 10-Q · filed 2020-08-05 | $65.33M 10-Q · filed 2020-08-05 | $95.90M derived: sum of 3 quarters · filed 2021-03-10 | $128.70M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | $32.22M 10-Q · filed 2020-05-07 | $62.79M derived: sum of 2 quarters · filed 2021-03-10 | $95.60M derived: sum of 3 quarters · filed 2021-03-10 | $126.63M derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | $30.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $63.38M derived: sum of 2 quarters · filed 2021-03-10 | $94.41M derived: sum of 3 quarters · filed 2021-03-10 | $121.31M 10-K · filed 2021-03-10 |
| 2018-09-30 | $32.80M 10-Q · filed 2019-11-07 | $63.84M derived: sum of 2 quarters · filed 2019-11-07 | $90.74M 10-Q · filed 2019-11-07 | $123.01M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-06-30 | $31.04M 10-Q · filed 2019-08-06 | $57.94M 10-Q · filed 2019-08-06 | $90.20M derived: sum of 3 quarters · filed 2020-05-20 | $108.58M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-03-31 | $26.90M 10-Q · filed 2019-05-08 | $59.17M derived: sum of 2 quarters · filed 2020-05-20 | $77.54M derived: sum of 3 quarters · filed 2020-05-20 | $92.67M derived: sum of 4 quarters · filed 2020-05-20 |
| 2017-12-31 | $32.27M derived: 8-K 12 month − 10-Q 9 month · filed 2020-05-20 | $50.64M derived: sum of 2 quarters · filed 2020-05-20 | $65.78M derived: sum of 3 quarters · filed 2020-05-20 | $78.80M 8-K · filed 2020-05-20 |
| 2017-09-30 | $18.38M 10-Q · filed 2018-11-07 | $33.51M derived: sum of 2 quarters · filed 2018-11-07 | $46.53M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $15.13M 10-Q · filed 2018-08-07 | $28.16M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $13.03M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $28.47M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $13.37M 10-K · filed 2018-03-08 |